What is NDC 59762-0104?

59762-0104 is the product NDC for Sulfasalazine, Sulfasalazine 500 mg/1 tablet, delayed release, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Sulfasalazine?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Sulfasalazine NDC 59762-0104 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-0104Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-0104Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59762-0104-5	5976201040559762010405	1 BOTTLE in 1 CARTON (59762-0104-5) / 100 TABLET, DELAYED RELEASE in 1 BOTTLEMarketed from Mar 23, 2020
59762-0104-6	5976201040659762010406	1 BOTTLE in 1 CARTON (59762-0104-6) / 300 TABLET, DELAYED RELEASE in 1 BOTTLEMarketed from Apr 6, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sulfasalazine
Generic name (nonproprietary): sulfasalazine
Active ingredients: Sulfasalazine — 500 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Mylan Pharmaceuticals Inc.NDC labeler code 59762
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 007073
Marketing start: May 5, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 59762-0104_0e53b1e5-3efe-4e5a-8d20-108f96490393SPL ID 0e53b1e5-3efe-4e5a-8d20-108f96490393SPL set ID 257cee60-b68f-4c2b-b57d-8e4d73d17e09RxCUI 313142UNII 3XC8GUZ6CBUPC 0359762010414
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762010405 followed by a unit qualifier and the quantity

Package 59762-0104-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 30, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sulfasalazine delayed release tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; b) for the prolongation of the remission period between acute attacks of ulcerative colitis; c) in the treatment of patients with rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs (e.g., an insufficient therapeutic response to, or intolerance of, an adequate trial of full doses of one or more nonsteroidal anti-inflammatory drugs); and d) in the treatment of pediatric patients with polyarticular-course 1 juvenile rheumatoid arthritis who have…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59762-0104

What is NDC 59762-0104?: 59762-0104 is the product NDC for Sulfasalazine, Sulfasalazine 500 mg/1 tablet, delayed release, listed with the FDA by Mylan Pharmaceuticals Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Sulfasalazine.
What is the active ingredient?: Sulfasalazine.
Who is the labeler?: Mylan Pharmaceuticals Inc., NDC labeler code 59762. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Sulfasalazine?: 11 other product NDCs are listed under this name. See all Sulfasalazine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Sulfasalazine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Sulfasalazine	Sulfasalazine 500 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-201	11534-0201-0111534-0201-07
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-261	16571-0261-0116571-0261-30
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Sunrise Pharmaceutical, Inc.	11534-200	11534-0200-0111534-0200-0411534-0200-07
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	0093-3234	00093-3234-0100093-3234-0500093-3234-10
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Bryant Ranch Prepack	63629-9715	63629-9715-01
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	REMEDYREPACK INC.	70518-1829	70518-1829-03
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	A-S Medication Solutions	50090-0086	50090-0086-04
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	A-S Medication Solutions	50090-6936	50090-6936-00
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-5000	59762-5000-0559762-5000-06
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-706	71610-0706-7071610-0706-80

All 12 Sulfasalazine NDCs

Other NDCs under NDA 007073

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 007073
Product	Strength	Form · route	Labeler	Product NDC
Azulfidinesulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Pfizer Laboratories Div Pfizer Inc	0013-0101
Azulfidine EN-tabssulfasalazine	Sulfasalazine 500 mg/1	Tablet, Delayed releaseOral	Pfizer Laboratories Div Pfizer Inc	0013-0102
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	A-S Medication Solutions	50090-0086
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	A-S Medication Solutions	50090-6936
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Mylan Pharmaceuticals Inc.	59762-5000
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	REMEDYREPACK INC.	70518-1829
Sulfasalazine	Sulfasalazine 500 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-706